Skip to content
value.today

BioHorizons, Inc.

Formerly BH Holdings I, Inc., BioHorizons Holdings, Inc., HealthpointCapital Dental Holdings, Inc.

Total raised
$52 M
2 rounds on record
Latest round
$2 M
Dec 2012
First round on record
Jun 2011
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of BioHorizons, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2012$2 MNo. 2Under $2 million

BioHorizons, Inc.: Raise no. 2, Dec 2012

Investors in this round

33 investors had bought by the notice of Dec 19, 2012: 4 accredited, 29 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David A. Wall · Executive Officer
  • David P. Dutil · Executive Officer
  • J. Todd S. Strong · Executive Officer
  • Kendyl D. Lowe · Executive Officer
  • R. Steven Boggan · Executive Officer, Director
  • David J, Hogan · Director
  • John H. Foster · Director
  • John J. Chopack, Jr. · Director
  • Mortimer P. Berkowitz III · Director
  • Robert H. Blankemeyer · Director
  • Siri S. Marshall · Director
  • Tom C. Davis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Rolling Common Stock issued to certain existing securityholders as part of the settlement of a lawsuit.”

Signed by David P. Dutil, SVP and General Counsel. Source: SEC Form D, newest notice filed Dec 19, 2012. Read the notice at the SEC.

equitySEC
Jun 2011$50 MNo. 1$50 to $250 million

BioHorizons, Inc.: Raise no. 1, Jun 2011

Investors in this round

6 investors had bought by the notice of Jul 29, 2011: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$50 M of $50 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$900,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Clark M. Barousse · Executive Officer
  • David A. Wall · Executive Officer
  • David P. Dutil · Executive Officer
  • J. Todd D. Strong · Executive Officer
  • Kendyl D. Lowe · Executive Officer
  • R. Steven Boggan · Executive Officer, Director
  • David J. Hogan · Director
  • John H. Foster · Director
  • John J. Chopack, Jr. · Director
  • Mortimer P. Berkowitz III · Director
  • Siri S. Marshall · Director
  • Tom C. Davis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Piper Jaffray & Co. (CRD 665) · Minneapolis, MinnesotaSold in MN, NY

Signed by David P. Dutil, Senior Vice President and General Counsel. Source: SEC Form D, newest notice filed Jul 29, 2011. Read the notice at the SEC.

equity, debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • BioHorizons, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2012).

    SEC Form D · Dec 2012

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2012

That is all the official record says: BioHorizons, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of BioHorizons, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 33 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by BioHorizons, Inc.
NameRoleNamed in
David A. WallExecutive officerDec 2012
David P. DutilExecutive officerDec 2012
J. Todd S. StrongExecutive officerDec 2012
Kendyl D. LoweExecutive officerDec 2012
R. Steven BogganExecutive officerDec 2012
Clark M. BarousseExecutive officerJul 2011
J. Todd D. StrongExecutive officerJul 2011
David J, HoganDirectorDec 2012
John H. FosterDirectorDec 2012
John J. Chopack, Jr.DirectorDec 2012
Mortimer P. Berkowitz IIIDirectorDec 2012
R. Steven BogganDirectorDec 2012
Robert H. BlankemeyerDirectorDec 2012
Siri S. MarshallDirectorDec 2012
Tom C. DavisDirectorDec 2012
David J. HoganDirectorJul 2011